経頸管的肝内門脈シャント市場：製品タイプ、手技タイプ、材料タイプ、用途、エンドユーザー別-2025-2030年世界予測

経頸管的肝内門脈シャント市場の2024年の市場規模は1億255万米ドルで、2025年には1億678万米ドルに成長し、CAGRは4.27%、2030年には1億3,181万米ドルに達すると予測されています。

経頸管的肝内ポートコステリックシャント（TIPS）は、門脈圧亢進症とそれに伴う合併症の管理において重要な治療法です。この包括的なエグゼクティブサマリーでは、TIPS市場の複雑なダイナミクスを掘り下げ、成長を促進し患者の治療成果を変革する技術革新、進化する手技、戦略的市場セグメンテーションについて詳述します。

医療の進歩が著しい今日、TIPSは肝硬変、門脈圧亢進症、バッド・キアリ症候群などの合併症の緩和を目的とした極めて重要な治療法として注目されています。臨床的な成功に加え、患者の安全性と手技後のケアが重視されるようになったことで、病院から専門クリニックまで、さまざまなエンドユーザーの関心が高まっています。規制情勢が進化し続け、新しい医療機器が治療の有効性を高める中、利害関係者は臨床試験や製品革新だけでなく、競争力学やコスト制約に結びついた手ごわい市場課題にも取り組んでいます。

本サマリーでは、TIPS市場内の変革的な変化、主要な業界動向を明らかにする厳密なセグメンテーションアプローチ、市場の持続的な成功を目指す業界リーダーのための戦略的提言を詳しく紹介します。質的・量的洞察に裏打ちされた分析は、急速に進化するヘルスケアパラダイムにおける戦略的意思決定を支える基盤となっています。

経頸管的肝内門脈シャント市場の変革

過去10年間、TIPSの状況は、市場の構造と価値提案を再定義する変革的な変化を遂げてきました。いくつかの重要な要因がこの進化を後押ししています。

重要な変化の一つは、技術革新のペースが加速していることです。TIPS用に特別に設計された医療機器は現在、高度な機能を誇り、シャント設置の精度が向上し、患者の転帰が改善されています。この進化は、臨床的有効性を検証する新たな調査によって補完され、医師と患者双方の信頼を高めています。バルーン拡張器からカテーテル、ガイディングワイヤーに至るまで、付属器具の開発は手技を近代化し、よりスムーズな手術と手術リスクの低減を可能にしました。

同時に、こうした技術革新に対応するため、大手メーカーや研究機関は研究開発に積極的な投資を行っています。規制機関もまた、安全性とコンプライアンスを確保しつつ、革新的な治療法の導入を支援するためにガイドラインを適応させています。こうした先進的な政策は、多くの地域での市場自由化と相まって、利害関係者に新たな臨床応用やプロセス改善を模索する十分な機会を提供しています。

もう一つの変革的な力は、臨床データと商業主導の洞察との融合です。治療機関は、製品開発を改良し、患者プロトコルを改善するために、実世界のエビデンスを活用するようになってきており、従来の治療方法から、より統合された、テクノロジーを駆使したアプローチへの転換を促しています。このようなデータ主導の考察と革新的な製品提供の融合により、競合情勢は一変し、機器メーカー、ヘルスケアプロバイダー、調査機関の間で協力や戦略的提携が行われるようになっています。

要するに、この市場は、従来の手技的手法から最先端技術の統合への顕著なシフトを経験しているだけでなく、より患者中心のアプローチへのシフトも経験しているのです。このような力学を効果的に利用する業界プレーヤーは、多様な患者層の臨床転帰を向上させながら、将来の市場成長を牽引する立場にあります。

TIPS市場の主要セグメンテーションインサイト

TIPS市場のセグメンテーション分析は、業界利害関係者が成長機会を特定し、市場の多様化を理解する上で役立つ多層的な視点を提供します。製品タイプ別に見ると、市場は主に付属器具とステントに分けられます。付属器具のセグメントでは、バルーン拡張器、カテーテル、ガイディングワイヤーなどのコンポーネントが綿密に調査されており、それぞれ手技の正確性と患者の安全性を向上させる上で重要な役割を果たしています。対照的に、ステントのカテゴリーでは、ベアメタルステント、薬剤溶出ステント、セクショナルステントに分類され、特定の臨床シナリオに合わせた素材とデザインの進化が強調されています。

手技の種類別では、選択的シャントと緊急シャントの両方を精査しています。緊急シャントでは、有効性を損なうことなく迅速な展開が求められることが多いため、一刻を争う状況下でプロトコールを合理化し、デバイスの信頼性を確保することに重点が置かれています。一方、選択的シャントでは、個々の患者のニーズに合わせて介入を行うために、計画手法や計算手法がより広範に開発されています。

耐久性と長期的な性能で知られる金属ステントと、柔軟性と費用対効果を提供するポリマーベースのソリューションに明確に分かれています。各素材の種類によって臨床上の利点やリスクプロファイルが異なるため、市場の導入や価格戦略に影響を与えます。

さらに、用途別セグメントを分析すると、この市場は肝臓関連の健康状態に幅広く対応するように設計されていることがわかる。Budd-Chiari症候群、C型肝炎、肝硬変、門脈圧亢進症などの病態は、TIPS手技の治療上の多様性を反映しているだけでなく、これらの複雑な疾患の管理における課題も浮き彫りにしています。最後に、エンドユーザーセグメントに基づく評価は、外来手術センター、病院、研究機関、専門クリニックを含む多様な範囲を示しています。この分布は、様々なヘルスケアインフラでTIPS処置が広く受け入れられ、有用であることを強調しており、市場需要をさらに強化し、機器クラス全体の技術革新を促しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 肝硬変や門脈圧亢進症などの肝疾患の増加
    • 回復時間が短いため、低侵襲手術の採用が増加
  • 抑制要因
    • 肝内門脈体循環シャント手術に伴う安全性の懸念と潜在的な合併症
  • 機会
    • 人工知能を活用したパーソナライズされたTIPS治療計画を開発し、患者の転帰を改善
    • 材料の技術的進歩を活用してTIPSデバイスの有効性と安全性を高める
  • 課題
    • TIPS処置に関連する不十分な保険適用と払い戻しの問題
• 市場セグメンテーション分析
  • 製品タイプ：低侵襲手術用アクセサリ機器の需要増加
  • 応用：門脈圧亢進症の治療におけるTIPS手順の必要性の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 経頸管的肝内門脈シャント市場：製品タイプ別

• アクセサリデバイス
  • バルーンエキスパンダー
  • カテーテル
  • ガイドワイヤー
• ステント
  • ベアメタルステント
  • 薬剤溶出ステント
  • セクショナルステント

第7章 経頸管的肝内門脈シャント市場手順の種類別

• 選択的シャント
• 緊急シャント

第8章 経頸管的肝内門脈シャント市場：素材タイプ別

• 金属ステント
• ポリマー

第9章 経頸管的肝内門脈シャント市場：用途別

• バッド・キアリ症候群
• C型肝炎
• 肝硬変
• 門脈圧亢進症

第10章 経頸管的肝内門脈シャント市場：エンドユーザー別

• 外来手術センター
• 病院
• 調査機関
• 専門クリニック

第11章 南北アメリカの経頸管的肝内門脈シャント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の経頸管的肝内門脈シャント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの経頸管的肝内門脈シャント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AngioDynamics Inc.
• Argon Medical Devices, Inc.
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cook Group Incorporated
• Medtronic
• Merit Medical Systems, Inc.
• Siemens Healthcare Limited
• Sirtex Medical Inc.
• Terumo Medical Corporation
• W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET MULTI-CURRENCY
• FIGURE 2. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET MULTI-LANGUAGE
• FIGURE 3. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET RESEARCH PROCESS
• FIGURE 4. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET DYNAMICS
• TABLE 7. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY BALLOON EXPANDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY GUIDING WIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY SECTIONAL STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ELECTIVE SHUNTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY EMERGENCY SHUNTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY POLYMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY BUDD-CHIARI SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY LIVER CIRRHOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PORTAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 58. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 59. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. CANADA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 95. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 96. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 97. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 98. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. CHINA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 102. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 103. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 105. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. INDIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 178. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 199. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 221. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 222. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 223. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 224. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 225. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. ITALY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 241. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 248. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 249. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 250. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 251. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 252. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 253. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 254. POLAND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 255. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 256. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 257. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 258. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 259. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 260. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 261. QATAR TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 262. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 269. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)

T

The Transjugular Intrahepatic Portosystemic Shunt Market was valued at USD 102.55 million in 2024 and is projected to grow to USD 106.78 million in 2025, with a CAGR of 4.27%, reaching USD 131.81 million by 2030.

The transjugular intrahepatic portosystemic shunt (TIPS) represents a critical intervention in the management of portal hypertension and its ensuing complications. This comprehensive executive summary delves into the complex dynamics of the TIPS market, detailing the technological innovations, evolving procedural techniques, and strategic market segmentation that drive growth and transform patient care outcomes.

In today's era of rapid medical advancement, TIPS procedures have emerged as a pivotal treatment option particularly aimed at alleviating complications associated with liver cirrhosis, portal hypertension, and conditions like Budd-Chiari Syndrome. Clinical successes combined with heightened emphasis on patient safety and post-procedure care have bolstered interest across a range of end-users from hospitals to specialty clinics. As regulatory landscapes continue to evolve and novel medical devices enhance the intervention's efficacy, stakeholders find themselves navigating not only clinical trials and product innovation but formidable market challenges tied to competitive dynamics and cost-constraints.

This summary provides an in-depth look at the transformative shifts within the TIPS market, rigorous segmentation approaches that illuminate key industry trends, and strategic recommendations designed for industry leaders targeting sustained market success. The analysis supported by qualitative and quantitative insights sets a foundation that underpins strategic decision-making in a rapidly evolving healthcare paradigm.

Transformative Shifts in the TIPS Market Landscape

Over the past decade, the TIPS landscape has undergone transformative shifts that have redefined the market's structure and value proposition. Several key factors are driving this evolution.

One significant shift is the accelerated pace of technological innovation. Medical devices specifically designed for TIPS now boast advanced features, greater precision in shunt placement, and improved patient outcomes. This evolution is complemented by new research studies that validate clinical efficacy, driving confidence among both practitioners and patients. The development of accessory devices-ranging from balloon expanders to catheters and guiding wires-has modernized procedural techniques, enabling smoother operations and reduced operative risks.

Concurrently, these innovations have been met with rigorous reinvestments in research and development driven by leading manufacturers and research institutes alike. Regulatory bodies are also adapting their guidelines to support the introduction of innovative therapies while ensuring safety and compliance. These forward-thinking policies, coupled with market liberalization in many regions, have provided ample opportunity for stakeholders to explore new clinical applications and process improvements.

Another transformative force is the merging of clinical data with commercially driven insights. Institutions are increasingly leveraging real-world evidence to refine product development and improve patient protocols, catalyzing a shift from traditional treatment modalities to more integrated, technology-enhanced approaches. This blend of data-driven insights and innovative product offerings has reshaped the competitive landscape, inviting collaboration and strategic alliances among device manufacturers, healthcare providers, and research agencies.

In essence, the market is experiencing a notable shift not only from conventional procedural methods to cutting-edge technological integration but also towards a more patient-centric approach. Industry players who effectively harness these dynamics are well positioned to drive future market growth while enhancing clinical outcomes for a diverse patient demographic.

Key Segmentation Insights in the TIPS Market

The segmentation analysis of the TIPS market provides a multi-layered view that assists industry stakeholders in identifying growth opportunities and understanding market diversification. In reviewing product type, the market is predominantly divided between accessory devices and stents. The segment for accessory devices is meticulously examined to include components such as balloon expanders, catheters, and guiding wires, each of which plays a vital role in improving procedural accuracy and patient safety. In contrast, the stent category is further nuanced into bare metal stents, drug-eluting stents, and sectional stents, highlighting the evolution of materials and design tailored to specific clinical scenarios.

A separate segmentation perspective is offered by procedure type, where both elective and emergency shunts are scrutinized. Recognizing that emergency shunts often require rapid deployment without compromising efficacy, there has been an emphasis on streamlining protocols and ensuring device reliability under time-sensitive conditions. This is balanced with elective shunts where the planning and computational methodologies are more extensively developed to tailor interventions to individual patient needs.

Material type segmentation also provides intriguing insights into the market's progression, with a clear division between metallic stents, known for their durability and long-term performance, and polymer-based solutions that offer flexibility and cost-effectiveness. Each material type demonstrates differing clinical benefits and risk profiles, which in turn influence market adoption and pricing strategies.

Moreover, analysing the application segment reveals that the market is designed to address a wide spectrum of liver-related health conditions. Conditions such as Budd-Chiari Syndrome, Hepatitis C, liver cirrhosis, and portal hypertension not only reflect the therapeutic versatility of TIPS procedures but also underscore the challenges in managing these complex diseases. Finally, evaluation based on end-user segments indicates a diverse range that includes ambulatory surgical centers, hospitals, research institutes, and specialty clinics. The distribution underscores the widespread acceptance and utility of TIPS procedures across various healthcare infrastructures, further bolstering market demand and encouraging innovation across device classes.

Based on Product Type, market is studied across Accessory Devices and Stents. The Accessory Devices is further studied across Balloon Expanders, Catheters, and Guiding Wires. The Stents is further studied across Bare Metal Stents, Drug-Eluting Stents, and Sectional Stents.

Based on Procedure Type, market is studied across Elective Shunts and Emergency Shunts.

Based on Material Type, market is studied across Metallic Stents and Polymers.

Based on Application, market is studied across Budd-Chiari Syndrome, Hepatitis C, Liver Cirrhosis, and Portal Hypertension.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, Research Institutes, and Specialty Clinics.

Regional Insights and Market Penetration Trends

An examination of regional trends reveals a multifaceted market with distinct growth patterns across geographies. The Americas have exhibited robust market growth driven by high healthcare spending, advanced clinical infrastructure, and strong research investments. There is significant adoption of TIPS procedures in this region, supported by a well-coordinated network of tertiary care centers and a proactive regulatory environment that facilitates innovation.

In the Europe, Middle East & Africa region, market dynamics are influenced by a combination of mature healthcare frameworks in developed European countries and evolving infrastructure in various MEA nations. Here, incremental investments in healthcare technology have enhanced the operational efficiency of TIPS procedures, while cross-border collaborations and knowledge-sharing initiatives are fostering greater clinical confidence.

The Asia-Pacific region is emerging as a critical growth driver for the TIPS market. Rapid urbanization, improving healthcare facilities, and increased access to cutting-edge medical interventions are fueling demand in this region. Local and international manufacturers are keenly tuning into the region's vast potential by customizing their product offerings to suit the demographic and clinical idiosyncrasies particular to diverse markets in Asia-Pacific. Collectively, these regional variations offer valuable insights that can assist market participants in tailoring their approaches to meet localized needs and drive sustained market penetration.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Strategic Insights into Leading Industry Players

A competitive analysis of the TIPS market underscores the presence of major players with significant influence over technological and clinical advancements in the field. Companies such as AngioDynamics Inc. and Argon Medical Devices, Inc. are at the forefront of driving product innovations, particularly in designing state-of-the-art accessory devices and advanced stent solutions. Their focus on developing balloon expanders, catheters, and guiding wires continues to set industry benchmarks for procedural efficiency and safety.

Becton, Dickinson and Company and Boston Scientific Corporation have harnessed their extensive research capabilities to introduce breakthrough technologies that enhance device performance while optimizing cost efficiency. The rigorous R&D efforts spearheaded by leaders like Cook Group Incorporated and Medtronic have been pivotal in ensuring that clinical outcomes are both safe and reproducible.

Merit Medical Systems, Inc. along with Siemens Healthcare Limited, have contributed to streamlining manufacturing processes, further refining the precision of TIPS-related devices. Sirtex Medical Inc., Terumo Medical Corporation, and W. L. Gore & Associates, Inc. have also carved niche yet decisive market segments by focusing on specific device innovations tailored to meet varied clinical requirements.

The strategic interplay among these top companies is fostering a competitive yet collaborative environment in the market. Their continuous improvements in device design, coupled with advancements in procedural technology, create immense value for healthcare providers. This, in turn, ensures that patient outcomes remain at the core of innovation, thereby delivering a blend of operational excellence and clinical safety that sustains industry growth over time.

The report delves into recent significant developments in the Transjugular Intrahepatic Portosystemic Shunt Market, highlighting leading vendors and their innovative profiles. These include AngioDynamics Inc., Argon Medical Devices, Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Cook Group Incorporated, Medtronic, Merit Medical Systems, Inc., Siemens Healthcare Limited, Sirtex Medical Inc., Terumo Medical Corporation, and W. L. Gore & Associates, Inc.. Actionable Recommendations for Growing Market Leaders

Industry leaders looking to secure a competitive edge in the TIPS market should embrace a multi-pronged strategy that promotes innovation, operational efficiency, and market adaptability. A primary recommendation is to advance research and development initiatives not only in terms of hardware-such as improving the design of accessory devices and stents-but also in integrating digital health technologies that allow for real-time data monitoring and outcomes analysis. Collaboration between surgeons, researchers, and technologists can pave the way for developing devices that are adaptable to both elective and emergency procedural demands.

Another essential strategy involves expanding the geographical footprint by tailoring device solutions to the unique needs of various regions. Understanding local regulatory frameworks and healthcare practices is key; thus, an investment in regional market research can unveil opportunities to customize products and streamline distribution channels. Leaders are encouraged to foster strong alliances with local hospitals, research institutes, and specialty clinics to build a resilient network that is capable of addressing both acute and chronic conditions linked to portal hypertension, liver cirrhosis, and other liver-associated diseases.

On the operational front, implementing best practices in manufacturing and quality assurance can significantly reduce production costs while enhancing reliability. By leveraging automation and adopting standardized protocols across multiple facilities, companies can achieve economies of scale and ensure consistent device quality irrespective of the production location.

Lastly, a robust post-market surveillance system is crucial in maintaining safety and efficacy benchmarks. Industry players should invest in systems that facilitate rapid feedback from healthcare providers, enabling quick adjustments to device design and procedural protocols. This proactive approach not only improves patient outcomes but enhances market reputation, supporting long-term brand loyalty and trust among medical professionals.

Collectively, these actionable strategies serve as a roadmap for leaders intent on not just maintaining relevance but also in spearheading innovation and operational excellence in the TIPS market.

Conclusion: Steering the Future of TIPS Interventions

In conclusion, the market for transjugular intrahepatic portosystemic shunt procedures is marked by dynamic changes that are rapidly redefining clinical practices and market structures. This comprehensive analysis has highlighted the significance of robust segmentation strategies, regional market trends, and competitive insights that together provide a holistic view of the industry landscape.

Innovation remains the cornerstone of progress in the TIPS market, with technological breakthroughs in accessory devices, stent designs, and procedural protocols playing a pivotal role in enhancing patient care. The evolution of both elective and emergency shunt procedures underscores a shift as stakeholders are increasingly focusing on precision, safety, and adaptability.

Strategic collaborations among industry leaders and continuous investments in R&D signal a future where high-performance devices become the norm. The dynamic interplay of market segmentation factors-from product types and material compositions to procedural approaches and end-user engagements-offers a detailed map for navigating the challenges and opportunities in this evolving space.

The insights presented herein empower decision-makers with the necessary tools to forge ahead in a competitive environment. By embracing innovation, improving operational efficiencies, and aligning with regional and global market trends, industry players can confidently steer the future of TIPS interventions toward enhanced clinical outcomes and sustained market growth.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of liver diseases such as cirrhosis and portal hypertension
    • 5.1.1.2. Increasing adoption of minimally invasive surgical procedures due to faster recovery times
  • 5.1.2. Restraints
    • 5.1.2.1. Safety concerns and potential complications associated with intrahepatic portosystemic shunt procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Developing personalized TIPS treatment plans leveraging artificial intelligence for better patient outcomes
    • 5.1.3.2. Capitalizing on technological advancements in materials to enhance TIPS device efficacy and safety
  • 5.1.4. Challenges
    • 5.1.4.1. Insufficient insurance coverage and reimbursement issues related to TIPS procedures
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Rising need for accessory devices for minimally invasive surgical procedures
  • 5.2.2. Application: Increasing necessity for TIPS procedure for curing portal hypertension
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Transjugular Intrahepatic Portosystemic Shunt Market, by Product Type

• 6.1. Introduction
• 6.2. Accessory Devices
  • 6.2.1. Balloon Expanders
  • 6.2.2. Catheters
  • 6.2.3. Guiding Wires
• 6.3. Stents
  • 6.3.1. Bare Metal Stents
  • 6.3.2. Drug-Eluting Stents
  • 6.3.3. Sectional Stents

7. Transjugular Intrahepatic Portosystemic Shunt Market, by Procedure Type

• 7.1. Introduction
• 7.2. Elective Shunts
• 7.3. Emergency Shunts

8. Transjugular Intrahepatic Portosystemic Shunt Market, by Material Type

• 8.1. Introduction
• 8.2. Metallic Stents
• 8.3. Polymers

9. Transjugular Intrahepatic Portosystemic Shunt Market, by Application

• 9.1. Introduction
• 9.2. Budd-Chiari Syndrome
• 9.3. Hepatitis C
• 9.4. Liver Cirrhosis
• 9.5. Portal Hypertension

10. Transjugular Intrahepatic Portosystemic Shunt Market, by End-User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Hospitals
• 10.4. Research Institutes
• 10.5. Specialty Clinics

11. Americas Transjugular Intrahepatic Portosystemic Shunt Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Transjugular Intrahepatic Portosystemic Shunt Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Transjugular Intrahepatic Portosystemic Shunt Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Argon Medical enhances TIPS procedure with innovative liver management devices
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AngioDynamics Inc.
• 2. Argon Medical Devices, Inc.
• 3. Becton, Dickinson and Company
• 4. Boston Scientific Corporation
• 5. Cook Group Incorporated
• 6. Medtronic
• 7. Merit Medical Systems, Inc.
• 8. Siemens Healthcare Limited
• 9. Sirtex Medical Inc.
• 10. Terumo Medical Corporation
• 11. W. L. Gore & Associates, Inc.